Piper Sandler: Intuitive Surgical Still Dominant in Soft-Tissue Robotics Despite J&J’s Ottava
Piper sees Intuitive Surgical staying ahead in robotic surgery, with strong growth potential despite rising competition.
Piper sees Intuitive Surgical staying ahead in robotic surgery, with strong growth potential despite rising competition.
GLP-1 drugs and insurance uncertainty weigh on demand.
Intuitive Surgical beats Q3 earnings expectations with strong da Vinci and Ion system sales, driving shares up 14% and prompting multiple analyst upgrades.